Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

She states symptoms as including: Pedra Lhermitte's Sign (electric shock sensation), facial pain, MS hug, heat intolerance, body jerks, cognitive fog, itching (pruritus), hypersensitivity to light, ...

Having multiple sclerosis (MS) was associated with higher rates of mental illness during the peripartum period than not ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Follow-up treatments and regular monitoring are essential for ongoing symptom management. Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...